Dexamethasone
- Level
- Commodity
- Parent
- 51422300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51422306This classification denotes a therapeutic glucocorticoid and antiemetic agent with the molecular formula C22H29FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7S5I7G3JQL, chemically known as 9-fluoro-11.beta.,17, 21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione but generally known as dexamethasone, which bears US NIH Compound Identifier 3003. European Medicines Agency schedules Dexamethasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07017MIG. The term DEXAMETHASONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules dexamethasone in its Anatomical Therapeutic Chemical (ATC) Classification. DEXAMETHASONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dexamethasone under HS 29372200 and SITC 54153. As of Q4 2014, DEXAMETHASONE remains the US FDA Preferred Term for this commodity. Dexamethasone bears US NLM identifiers UMLS ID C0011777 and NCI Concept Code C422. SMILES: FC12C(C3C(C(O)(C(C3)C)C(=O)CO)(CC1O)C)CCC1=CC(=O)C=CC21C.
Same parent
Under 51422300 · 70Activities that produce or sell this
KBLI · 9Inherited from family 51420000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.